OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial

Moeller, DS, Hoffmann, L, Lutz, CM et al. (10 more authors) (2016) OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2019, Turin, Italy. Elsevier , S259-S259.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: Copyright © 2016 Elsevier Ireland Ltd. This is an open access article under the terms of the CC-BY-NC-ND 4.0 licence: https://creativecommons.org/licenses/by-nc-nd/4.0/
Dates:
  • Accepted: 17 December 2015
  • Published (online): 21 August 2016
  • Published: April 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 17 May 2019 08:16
Last Modified: 17 May 2019 11:18
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S0167-8140(16)31794-7
Related URLs:

Share / Export

Statistics